OFFICIAL PUBLICATION OF

by its subsidiary APPco

MSD melanoma drug listed

Megan Haggan 20/04/2015

melanoma: dermatologist examines mole on woman's shoulder

A new treatment for advanced melanoma which has seen significant media attention is now available in Australia. MSD announced that its anti-PD1 immunotherapy KEYTRUDA (pembrolizumab) has been registered by the TGA for the treatment of the most deadly form of skin cancer – advanced melanoma. The treatment has been the subject of a Change.org petition

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Doctor title ‘recognition and respect you deserve’

A huge amount of John's comments are outright xenophobic. There is no point trying to reason with someone who thinks…

Siya Etzebeth

Doctor title ‘recognition and respect you deserve’

Still not answering the question. Just building up more strawmen. If you're confident that you are correct then stop lying…

Siya Etzebeth

Doctor title ‘recognition and respect you deserve’

The Guild doesn't "direct" anyone openly but they hold a lot of power and it's either nieve or disingenous to…

John Smith

Doctor title ‘recognition and respect you deserve’

I honestly don’t know why engage with such a childish response but I’ll give it one more go. I said…

John Smith

MSD melanoma drug listed

Previous Council urges Aussies to consider bowel cancer

Next TGA upgrades eBusiness website

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Council urges Aussies to consider bowel cancer

Next TGA upgrades eBusiness website

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.